The biopharmaceutical aspects of nasal mucoadhesive drug delivery
The DOI matches its Crossref record; 125 of the 131 references it cites were found in a registry or an index.
Abstract
Nasal drug administration has frequently been proposed as the most feasible alternative to parenteral injections. This is due to the high permeability of the nasal epithelium, allowing a higher molecular mass cut-off at approximately 1000 Da, and the rapid drug absorption rate with plasma drug profiles sometimes almost identical to those from intravenous injections. Despite the potential of nasal drug delivery, it has a number of limitations. In this review, the anatomy and physiology of the nasal cavity, as well as ciliary beating and mucociliary clearance as they relate to nasal drug absorption, are introduced. The rationale for nasal drug delivery and its limitations, some factors that influence nasal drug absorption, and the experimental models used in nasal drug delivery research are also reviewed. Nasal mucoadhesion as a promising method of nasal absorption enhancement is discussed, and factors that influence mucoadhesion, as well as safety of nasal mucoadhesive drug delivery systems are reviewed in detail. Nasal drug administration is presently mostly used for local therapies within the nasal cavity. Anti-allergic drugs and nasal decongestants are the most common examples. However, nasal drug administration for systemic effects has been practised since ancient times. Nasally-administered psychotropic drugs by native Americans, the use of tobacco snuffs, and nasal administration of illicit drugs such as cocaine are all well known (Illum & Davis 1992). Nowadays, the nasal cavity is being actively explored for systemic administration of other therapeutic agents, particularly peptides and proteins (Illum 1992; Edman & Bjork 1992), as well as for immunization purposes (Lemoine et al 1998). To better understand the basis for nasal drug absorption and factors that can influence it, a brief review of the anatomy and physiology of the nose is appropriate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Textbook of Medical Physiology
(1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-6-1363_2 · Cited by 9,749
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues
Peppas, N. A., & Buri, P. A. (1985) · Journal of Controlled Release · doi:10.1016/0168-3659(85)90050-1 · Cited by 710 · cited 1×
“Polyanionic polymers are preferred over polycationic polymers with regard to bioadhesiveness (Park et al 1984; Peppas 1985; Leung & Robinson 1988; Duche# ne & Ponchel 1993).”
BackgroundThe Theory and Practice of Industrial Pharmacy
Fox, S. H. (1970) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600591047 · Cited by 609
Textbook of Medical Physiology
(1956) · Journal of the American Medical Association · doi:10.1001/jama.1956.02970160079021 · Cited by 517
An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery
Smart, J. D., Kellaway, I. W., & Worthington, H. E. C. (1984) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1984.tb04377.x · Cited by 467 · cited 2×
“It has been reported that increased contact timeandappliedpressure increase the adhesiveness of a polymer (Smart et al 1984; Park & Robinson 1985; Leung & Robinson 1990).”
BackgroundWheater's Functional Histology: A Text and Colour Atlas
Young, B., O'Dowd, G., & Woodford, P. (1993) · Cited by 436
Mechanisms of Mucoadhesion of Poly(acrylic Acid) Hydrogels
Park, H., & Robinson, J. R. (1987) · Pharmaceutical Research · doi:10.1023/a:1016467219657 · Cited by 360
Evaluation of the clearance characteristics of bioadhesive systems in humans
Soane, R. J., Frier, M., Perkins, A. C., Jones, N. S., Davis, S. S., & Illum, L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00367-6 · Cited by 360 · cited 1×
“Substances administered intranasally are rapidly cleared from human nose, with a clearance half-life of approximately 21 min (Soane et al 1999).”
BackgroundAnatomy, physiology and function of the nasal cavities in health and disease
Mygind, N., & Dahl, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00058-6 · Cited by 344 · cited 1×
“The basal cells subsequently differentiate to form other epithelial cell types and are also believed to help the columnar cells adhere to the basement membrane (Mygind & Dahl 1998).”
BackgroundPharmaceutical and Medical Aspects of Bioadhesive Systems for Drug Administration
Duchěne, D., Touchard, F., & Peppas, N. A. (1988) · Drug Development and Industrial Pharmacy · doi:10.3109/03639048809151972 · Cited by 333
Effects of physicochemical properties and other factors on systemic nasal drug delivery
Behl, C. R., Pimplaskar, H. K., Sileno, A. P., deMeireles, J., & Romeo, V. D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00063-x · Cited by 312 · cited 2×
“A recent review by Behl et al (1998) provided a list of 14 prescription and 33 OTC nasal products available on the market, and as many as 46 different investigational drugs that have reached the stage of human studies.”
BackgroundLectin-carbohydrate complexes of plants and animals: an atomic view
Sharon, N. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90193-q · Cited by 281 · cited 1×
“These are non-immunogenic proteins or glycoproteins capable of specific recognition and reversible binding to carbohydrate moieties of complex glycoconjugates without altering the covalent nature of any of the recognized glycosyl ligands (Sharon 1993).”
BackgroundThe Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies
Audus, K. L., Bartel, R. L., Hidalgo, I. J., & Borchardt, R. T. (1990) · Pharmaceutical Research · doi:10.1023/a:1015800312910 · Cited by 267
Absorption of drugs from the nasal mucosa of rat
Shinichiro, H., Takatsuka, Y., Tai, M., & Hiroyuki, M. (1981) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(81)90058-2 · Cited by 249
Nasal delivery systems and their effect on deposition and absorption
Kublik, H., & Vidgren, M. T. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00067-7 · Cited by 248 · cited 2×
“Delivery devices are also available for nasal gels (Kublik & Vidgren 1998).”
BackgroundPhysico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion
Park, H., & Robinson, J. R. (1985) · Journal of Controlled Release · doi:10.1016/0168-3659(85)90032-x · Cited by 243 · cited 3×
“methacrylic acid required a critical applied pressure for adhesion to occur, polyacrylic acid and polymethacrylic acid requires no applied pressure for interaction with mucin (Park & Robinson 1985).”
BackgroundThe Physiology of Cilia and Mucociliary Interactions
Satir, P., & Sleigh, M. A. (1990) · Annual Review of Physiology · doi:10.1146/annurev.ph.52.030190.001033 · Cited by 241 · cited 11×
“Cigarette smoking also decreases the MCC rate due to its influence on mucus rheology and}or reduction in the number of cilia, since it has no effect on CBF (Stanley et al 1986).”
BackgroundInfluentialPonchel, G., Touchard, F., Duchêne, D., & Peppas, N. A. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90004-6 · Cited by 233
Topics in Pharmaceutical Sciences
Yalkowsky, S. H. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600720233 · Cited by 220
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
Lee, V. H. L., Yamamoto, A., & Kompella, U. B. (1991) · PubMed · Cited by 213
Madsen, F. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00138-7 · Cited by 206
Mucoadhesive Drug Delivery Systems
Jiménez-castellanos, M. R., Zia, H., & Rhodes, C. T. (1993) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049309038765 · Cited by 203
Chien, Y. W., Su, K. S. E., & Chang, S.-F. (1989) · Cited by 188
Kaliner, M., Marom, Z. M., Patow, C., & Shelhamer, J. H. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90403-2 · Cited by 187 · cited 1×
“1% lipids (Kaliner et al 1984).”
Bioadhesive intraoral release systems: design, testing and analysis
Gurny, R., Meyer, J.-M., & Peppas, N. A. (1984) · Biomaterials · doi:10.1016/0142-9612(84)90031-0 · Cited by 169 · cited 2×
“This requirement may be relevant only for bioadhesion in the gel form (Gurny et al 1984).”
BackgroundEffect of cigarette smoking on nasal mucociliary clearance and ciliary beat frequency.
Stanley, P. J., Wilson, R., Greenstone, M. A., MacWilliam, L., & Cole, P. J. (1986) · Thorax · doi:10.1136/thx.41.7.519 · Cited by 164 · cited 11×
“Cigarette smoking also decreases the MCC rate due to its influence on mucus rheology and}or reduction in the number of cilia, since it has no effect on CBF (Stanley et al 1986).”
BackgroundInfluentialBioadhesive polymers for the peroral delivery of peptide drugs
Lueßen, H. L., Lehr, C.-M., Rentel, C.-O., Noach, A. B. J., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90078-7 · Cited by 163 · cited 4×
“…and paracellular transport (O’Hagan et al 1990; Uchida et al 1991) with the latter as a result of the influence on tight junction regulation (Leußen et al 1994; Ganem-Quintanar et al 1997), enzyme inhibition (Morimotoet al 1991b;Leußen et al 1994), influence on the thermodynamic…”
BackgroundInfluentialMuranishi, S. (1990) · PubMed · Cited by 154
Nasal absorption of propranolol from different dosage forms by rats and dogs
HUSSAIN, A. A., Hirai, S., & Bawarshi, R. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600691215 · Cited by 150 · cited 1×
“Hussain et al (1980) suggested that it is important to close the palatine during drug absorption studies.”
BackgroundThe contribution of anionic polymer structural features to mucoadhesion
Leung, S.-H. S., & Robinson, J. R. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(88)90021-1 · Cited by 148 · cited 1×
“Polyanionic polymers are preferred over polycationic polymers with regard to bioadhesiveness (Park et al 1984; Peppas 1985; Leung & Robinson 1988; Duche# ne & Ponchel 1993).”
BackgroundAbsorption Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats
Merkus, F. W. H. M., Verhoef, J. C., Romeijn, S. G., & Schipper, N. G. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015896405389 · Cited by 146
Sanderson, M. J., & Dirksen, E. R. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.2.432 · Cited by 146 · cited 11×
“Cigarette smoking also decreases the MCC rate due to its influence on mucus rheology and}or reduction in the number of cilia, since it has no effect on CBF (Stanley et al 1986).”
BackgroundInfluentialPeppas, N. A. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90109-7 · Cited by 135
Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man
Geppetti, P., Fusco, B. M., Marabini, S., Maggi, C. A., Fanciullacci, M., & Sicuteri, F. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb10305.x · Cited by 132 · cited 1×
“…in causing the release of neuropeptides such as substance P, somatostatin and calcitonin gene-related peptide from the nasal mucosal neurons, epithelial cells, mast cells and leucocytes, which may in turn induce the sneeze reflex and nasal secretion (Geppetti et al 1988; Walker et al 1988).”
BackgroundPolymer structure features contributing to mucoadhesion. II
Leung, S.-H. S., & Robinson, J. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90099-f · Cited by 128 · cited 2×
“It involves interaction between mucin and a synthetic or natural polymer leading to a net attraction (Leung & Robinson 1990).”
BackgroundStratford, R. E., & Lee, V. H. L. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90137-7 · Cited by 126 · cited 1×
“Nasal mucosal proteolytic enzymes have been reported to reduce nasal absorption of peptides (Hussain et al 1985, 1990b, 1992; Stratford & Lee 1986).”
BackgroundHägerström, H., Paulsson, M., & Edsman, K. L. M. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00070-6 · Cited by 124 · cited 1×
“Hagerstrom et al (2000) also reported a concentration-dependent rheological interaction between mucin and the polymers, Carbopol and Gelrite.”
BackgroundIn vitro cell models to study nasal mucosal permeability and metabolism
Schmidt, M. C., Peter, H., Lang, S. R., Ditzinger, G., & Merkle, H. P. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00061-6 · Cited by 123 · cited 1×
“It is also easier to separate the process of drug permeation across the epithelium from subsequent events such as biodistribution and elimination, as well as local blood flow (Schmidt et al 1998).”
BackgroundMadsen, F., Eberth, K., & Smart, J. D. (1998) · Biomaterials · doi:10.1016/s0142-9612(98)00037-4 · Cited by 123
Huang, C. H., Kimura, R., Bawarshi, R., & HUSSAIN, A. A. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740605 · Cited by 123
beta-Adrenergic stimulation of respiratory ciliary activity
Verdugo, P., Johnson, N. T., & Tam, P. Y. (1980) · Journal of Applied Physiology · doi:10.1152/jappl.1980.48.5.868 · Cited by 117 · cited 1×
“The increased CBF caused by isoprenaline can be blocked by propranolol, suggesting that the effect is via α-adrenergic receptors (Verdugo et al 1980).”
BackgroundLectin-mediated transport of nanoparticles across Caco-2 and OK cells
Russell-Jones, G. J., Veitch, H. S., & Arthur, L. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00254-9 · Cited by 116 · cited 1×
“…to sugar residues and the recent finding that uptake of lectin-coated nanoparticles is dependent on the density of the coating but not on the type and size of lectin (Russell-Jones et al 1999), it could be predicted that lectin-mediated mucoadhesion would be very useful for nasal drug delivery.”
BackgroundThe preservation and regeneration of cilia on human nasal epithelial cells cultured in vitro
Jorissen, M., der Schueren, B. V., BERGHE, H. V. D., & Cassiman, J. J. (1989) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/bf00463582 · Cited by 115
The relevance of nasal physiology to the design of drug absorption studies
Gizurarson, S. S. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90015-v · Cited by 114 · cited 1×
“There are several factors ranging from physiological conditions, physicochemical properties of the drug, to the administration device (Chien et al 1989; Gizurarson 1993).”
BackgroundRhinitis: Mechanisms and Management
Naclerio, R. M., Durham, S. R., & Mygind, N. (1998) · Medical Entomology and Zoology · Cited by 107
Bioadhesive and formulation parameters affecting nasal absorption
Dondeti, P. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04115-x · Cited by 97 · cited 1×
“The types of polymers used to improve the nasal bioavailability of several drugs and the levels of improved bioavailability obtained have been comprehensively reviewed elsewhere (Kamath & Park 1994; Dondeti et al 1996).”
BackgroundMorimoto, K., Yamaguchi, H., Iwakura, Y., Morisaka, K., Ohashi, Y., & Nakai, Y. (1991) · Pharmaceutical Research · doi:10.1023/a:1015894910416 · Cited by 90
Kissel, T., & Werner, U. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00253-8 · Cited by 85 · cited 1×
“Human nasal epithelial cells in primary culture that attain confluency and express tight junctions, thus suitable for both transport and metabolic studies, have been reported (Kissel & Werner 1998).”
BackgroundEzpeleta, I., Arangoa, M. A., Irache, J. M., Stainmesse, S., Chabenat, C., Popineau, Y., & Orecchioni, A. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00232-x · Cited by 85 · cited 1×
“Although these lectins have yet to be investigated for use in nasal mucoadhesive drug delivery, they have proved very useful as drug targeting agents, enhancing drug delivery to the GIT (Irache 1994; Naisbett & Woodley 1995a, b; Ezpeleta et al 1999), and ocular cavity (Nicholls 1996).”
BackgroundIn-vitro bioadhesion of carbopol hydrogels
Blanco-Fuente, H. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04665-0 · Cited by 84
Ponchel, G., Touchard, F., Wouessidjewe, D., Duchêne, D., & Peppas, N. A. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90098-6 · Cited by 84
Conditioning Surfaces to Suit the Biomedical Environment: Recent Progress
Baier, R. E. (1982) · Journal of Biomechanical Engineering · doi:10.1115/1.3138358 · Cited by 81 · cited 1×
“These include: adhesion between two normal cells ; adhesion of cells to foreign materials ; adhesion of normal cells to pathological cells ; and adhesion of an adhesive (polymer) to a biological tissue (Baier 1982; Gayot 1985; Longer & Robinson 1986).”
BackgroundThe Molecular Weight Dependence of Nasal Absorption: The Effect of Absorption Enhancers
Donovan, M. D., Flynn, G. L., & Amidon, G. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015904730599 · Cited by 71
SATOH, K., Takayama, K., Machida, Y., Suzuki, Y., Nakagaki, M., & Nagai, T. (1989) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.37.1366 · Cited by 70 · cited 1×
“Satoh et al (1989) reported an inter-polymer complex between Carbopol 934 and hydroxypropyl cellulose below pH 4.5 due to hydrogen bonding.”
BackgroundInfluentialMechanisms of oral permeation enhancement
Ganem-Quintanar, A., Kalia, Y. N., Falson, F., & Buri, P. A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00193-2 · Cited by 68 · cited 2×
“…on tight junction regulation (Leußen et al 1994; Ganem-Quintanar et al 1997), enzyme inhibition (Morimotoet al 1991b;Leußen et al 1994), influence on the thermodynamic activity of the drug (Uchida et al 1991), and increasing fluidity of the membrane lipid bilayer (Ganem-Quintanar et al 1997).”
BackgroundEnnis, R. D., Borden, L., & Lee, W. A. (1990) · Pharmaceutical Research · doi:10.1023/a:1015856430657 · Cited by 67
Nasal Absorption Enhancers for Biosynthetic Human Growth Hormone in Rats
O’Hagan, D. T., Critchley, H., Farraj, N. F., Fisher, A. N., Johansen, B. R., Davis, S. S., & Illum, L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015884026056 · Cited by 67
Ugwoke, M. I., Sam, E., den Mooter, G. V., Verbeke, N., & Kinget, R. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00061-5 · Cited by 66
Self-citationThe effects of preservatives on the ciliary beat frequency of chicken embryo tracheas.
van de Donk, H. J. M., Ip, M.-P., Zuidema, J., & Merkus, F. W. H. M. (1980) · PubMed · Cited by 66
Absorption of recombinant methionyl-human growth hormone (Met-hGH) from rat nasal mucosa
Daugherty, A. L., Liggitt, H. D., McCabe, J. G., Moore, J. A., & Patton, J. S. (1988) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(88)90289-x · Cited by 65 · cited 1×
“Laureth-9, sodiumdodecyl sulfate, sodium deoxycholate, sodium taurodeoxycholate and STDHF all caused epithelial disruption (Daugherty et al 1988; Donovan et al 1990; Ennis et al 1990; Chandler et al 1991b).”
BackgroundHuang, C. H., Kimura, R., Bawarshi, R., & HUSSAIN, A. A. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600741210 · Cited by 64
Werner, U., & Kissel, T. (1996) · Pharmaceutical Research · doi:10.1023/a:1016038119909 · Cited by 63
The Effect of Some Preservatives Used in Nasal Preparations on Mucociliary Clearance
Lansley, A. B., Marriott, C., Martin, G. P., & Bond, S. W. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06420.x · Cited by 62 · cited 1×
“It however requires thorough and regular cleaning, is prone to bacterial contamination, and frequently require the incorporation of preservatives which could be cilio-toxic (van de Donk et al 1980; Batts et al 1989).”
BackgroundShao, Z., & Mitra, A. K. (1992) · Pharmaceutical Research · doi:10.1023/a:1015808023310 · Cited by 61
Ugwoke, M. I., Agu, R. U., Vanbilloen, H. P., Baetens, J. D., Augustijns, P., Verbeke, N., Mortelmans, L. A., Verbruggen, A., Kinget, R., & Bormans, G. M. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00258-3 · Cited by 61
Self-citationEvaluation of possible mechanism(s) of bioadhesion
Tur, K. M., & Ch'ng, H.-S. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00297-4 · Cited by 60
Baldwin, P. A., Klingbeil, C., Grimm, C. J., & Longenecker, J. P. (1990) · Pharmaceutical Research · doi:10.1023/a:1015885204249 · Cited by 57
Regulation of ciliary beat frequency by autonomic mechanisms: in vitro
Wong, L. B., Miller, I. F., & Yeates, D. B. (1988) · Journal of Applied Physiology · doi:10.1152/jappl.1988.65.4.1895 · Cited by 56 · cited 1×
“Some sympathomimetics and parasympathomimetics (fenoterol, terbutaline, isoprenaline, methacholine) cause an increase in CBF of both human and non-human species (Wong et al 1988; Sanderson & Dirksen 1989; Agu et al 1999).”
BackgroundMucociliary clearance and drug delivery via the respiratory tract
Lansley, A. B. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90014-u · Cited by 55 · cited 1×
“These glands are composed of both mucus cells (which secrete the mucus gels) and serous cells that produce a watery fluid (Lansley 1993).”
BackgroundEffects of Proteolytic Enzyme Inhibitors on the Nasal Absorption of Vasopressin and an Analogue
Morimoto, K., Yamaguchi, H., Iwakura, Y., Miyazaki, M., Nakatani, E., Iwamoto, T., Ohashi, Y., & Nakai, Y. (1991) · Pharmaceutical Research · doi:10.1023/a:1015862603939 · Cited by 53
Newman, S. P., Steed, K. P., Hardy, J. G., Wilding, I. R., Hooper, G., & Sparrow, R. A. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03877.x · Cited by 53 · cited 1×
“Newman et al (1994) studied four modes of administration (80–160 µL volumes administered at gentle or vigorous inhalation air flows) and clearance in man.”
BackgroundHUSSAIN, A. A., Faraj, J. A., Aramaki, Y., & Truelove, J. E. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91224-0 · Cited by 51 · cited 2×
“Nasal mucosal proteolytic enzymes have been reported to reduce nasal absorption of peptides (Hussain et al 1985, 1990b, 1992; Stratford & Lee 1986).”
BackgroundUgwoke, M. I., Sam, E., den Mooter, G. V., Verbeke, N., & Kinget, R. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00018-6 · Cited by 51
Self-citationIn vitro study of lectin-latex conjugates for specific bioadhesion
Irache, J. M., Durrer, C., Duchêne, D., & Ponchel, G. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)00033-6 · Cited by 50
Walker, K., Serwonska, M. H., Valone, F. H., Harkonen, W. S., Frick, O. L., Scriven, K. H., Ratnoff, W. D., Browning, J. G., Payan, D. G., & Goetzl, E. J. (1988) · Journal of Clinical Immunology · doi:10.1007/bf00917898 · Cited by 49
Effect of Viscosity on the Pharmacokinetics and Biological Response to Intranasal Desmopressin
Harris, A. S., Ohlin, M., Svensson, E., Lethagen, S., & Nilsson, I. M. (1989) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600780610 · Cited by 48
Thaete, L. G., Spicer, S. S., & Spock, A. (1981) · American Journal of Anatomy · doi:10.1002/aja.1001620306 · Cited by 47 · cited 1×
“Heterogeneity exists between the cytochemical characteristics of mucus secretion from seromucus glands and goblet cells (Thaete et al 1981).”
BackgroundNasal absorption in rats. II. Effect of enhancers on insulin absorption and nasal histology
Chandler, S. G., Ilium, L., & Thomas, N. W. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90344-n · Cited by 44 · cited 3×
“Laureth-9, sodiumdodecyl sulfate, sodium deoxycholate, sodium taurodeoxycholate and STDHF all caused epithelial disruption (Daugherty et al 1988; Donovan et al 1990; Ennis et al 1990; Chandler et al 1991b).”
BackgroundAgu, R. U., Jorissen, M., Willems, T., den Mooter, G. V., Kinget, R. D., Verbeke, N., & Augustijns, P. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00342-7 · Cited by 44 · cited 1×
“…in-vitro ciliogenesis with actively beating cilia for several months (Jorissen et al 1989), has recently been validated (Agu et al 1999) and applied for the assessment of cilio-toxicity of nasal formulations and 17Nasal mucoadhesive drug delivery excipients (Agu et al 2000; Ugwoke et al 2000b, c).”
BackgroundSelf-citationGizurarson, S. S., Marriott, C., Martin, G. P., & Bechgaard, E. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90149-x · Cited by 43 · cited 1×
“Sodium glycholate and didecanoyl--αphosphatidylcholine have no effect on MCC, whereas lysophosphatidylcholine, laureth-9, sodium dihydrofusidate, sodium desoxycholate and dimethyl-α-cyclodextrin have ciliostatic effects (Gizurarson et al 1990; Merkus et al 1991).”
BackgroundSilberberg, A. (1990) · Biorheology · doi:10.3233/bir-1990-273-408 · Cited by 43 · cited 1×
“Due to their ATPase activity, the dynein arms provide the energy required for ciliary beating (Lindberg 1997).”
BackgroundPharmacokinetics and Bioavailability of Hydromorphone: Effect of Various Routes of Administration
Chang, S.-F., Moore, L., & Chien, Y. W. (1988) · Pharmaceutical Research · doi:10.1023/a:1015959912021 · Cited by 41
Olanoff, L. S., Titus, C., Shea, M., Gibson, R. E., & Brooks, C. D. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113148 · Cited by 41 · cited 1×
“Larsen et al (1987) reported that histamine-induced rhinitis did not influence nasal absorption of buserelin, whereas Olanoff et al (1987) reported that the nasal absorption of desmopressin was improved after a similar treatment.”
BackgroundTos, M. (1983) · PubMed · Cited by 40
Ugwoke, M. I., Agu, R. U., Jorissen, M., Augustijns, P., Sciot, R., Verbeke, N., & Kinget, R. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00082-2 · Cited by 39
Self-citationPhysicochemical determinants of nasal drug absorption
Gibson, R. E., & Olanoff, L. S. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90089-7 · Cited by 35
Agu, R. U., Jorissen, M., Willems, T., den Mooter, G. V., Kinget, R. D., & Augustijns, P. (1999) · Pharmaceutical Research · doi:10.1023/a:1018994807746 · Cited by 34
Self-citation(D) Routes of delivery: Case studies
Edman, P., & Björk, E. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90001-7 · Cited by 34
Recovery of Rat Nasal Mucosa from the Effects of Aminopeptidase Inhibitors
Hussain, M. A., Koval, C. A., Shenvi, A. B., & Aungst, B. J. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790507 · Cited by 34
Raphael, J., Selwyn, D. A., MOTTRAM, S. D., Langton, J. A., & O’Callaghan, C. (1996) · British Journal of Anaesthesia · doi:10.1093/bja/76.1.116 · Cited by 34
The potential use of tomato lectin for oral drug delivery: 3. Bioadhesion in vivo
Naisbett, B., & Woodley, J. M. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00242-w · Cited by 33 · cited 1×
“Although these lectins have yet to be investigated for use in nasal mucoadhesive drug delivery, they have proved very useful as drug targeting agents, enhancing drug delivery to the GIT (Irache 1994; Naisbett & Woodley 1995a, b; Ezpeleta et al 1999), and ocular cavity (Nicholls 1996).”
BackgroundNicholls, T. J. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04540-1 · Cited by 33
Ugwoke, M. I., Agu, R. U., Jorissen, M., Augustijns, P., Sciot, R., Verbeke, N., & Kinget, R. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00484-1 · Cited by 33
Self-citationChandler, S. G., Thomas, N. W., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018970006935 · Cited by 32
Raphael, J., Strupish, J. W., Selwyn, D. A., Hann, H. C. L., & Langton, J. A. (1996) · British Journal of Anaesthesia · doi:10.1093/bja/76.6.854 · Cited by 32
Smart, J. D., Nicholls, T. J., Green, K. L., Rogers, D. J., & Cook, J. D. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00050-0 · Cited by 30 · cited 1×
“Interestingly, some lectins have also been reported to show very low toxicity after intradermal injection (Smart et al 1999).”
BackgroundThe Microbial Ecology and Immunology of the Adenoid: Implications for Otitis Media
Bernstein, J. M., Reddy, M. S., Scannapieco, F. A., Faden, H. S., & Ballow, M. C. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51876.x · Cited by 30 · cited 1×
“The production of immunoglobulin A by both the adenoid tissue and the nasal mucosa plays a very important role in immune protection against bacteria and viruses (Bernstein et al 1997).”
BackgroundWell-differentiated thyroid carcinomas: p53 mutation status and microvessel density
Goldenberg, J. D., Portugal, L. G., Wenig, B. L., Ferrer, K., Wu, J. C., & Sabnani, J. (1998) · Head & Neck · doi:10.1002/(sici)1097-0347(199803)20:2<185::aid-hed17>3.0.co;2-l · Cited by 29
Nasal delivery of progestational steroids in ovariectomized rabbits
Corbo, D. C., Huang, Y. C., & Chien, Y. W. (1988) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(88)90018-x · Cited by 28 · cited 1×
“A novel drug delivery device was introduced by Corbo et al (1988) for controlled nasal drug delivery.”
BackgroundChandler, S. G., Illum, L., & Thomas, N. W. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90159-l · Cited by 28 · cited 3×
“Laureth-9, sodiumdodecyl sulfate, sodium deoxycholate, sodium taurodeoxycholate and STDHF all caused epithelial disruption (Daugherty et al 1988; Donovan et al 1990; Ennis et al 1990; Chandler et al 1991b).”
BackgroundJorissen, M., & Bessems, A. (1995) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/bf02114748 · Cited by 27
Nasal Administration: A Tool for Tomorrow's Systemic Administration of Drugs
Duchêne, D., & Ponchel, G. (1993) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049309038763 · Cited by 26 · cited 1×
“Polyanionic polymers are preferred over polycationic polymers with regard to bioadhesiveness (Park et al 1984; Peppas 1985; Leung & Robinson 1988; Duche# ne & Ponchel 1993).”
BackgroundUchida, N., Maitani, Y., Machida, Y., Nakagaki, M., & Nagai, T. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90226-e · Cited by 25 · cited 2×
“…on tight junction regulation (Leußen et al 1994; Ganem-Quintanar et al 1997), enzyme inhibition (Morimotoet al 1991b;Leußen et al 1994), influence on the thermodynamic activity of the drug (Uchida et al 1991), and increasing fluidity of the membrane lipid bilayer (Ganem-Quintanar et al 1997).”
BackgroundNasal vaccines - From fundamental concepts to vaccine development
Lemoine, D., Francotte, M., & Préat, V. (1998) · DIAL (Catholic University of Leuven) · Cited by 23
Larsen, C., J�rgensen, M. N., Tommerup, B., Mygind, N., Dagrosa, E. E., Grigoleit, H.-G., & Malerczyk, V. (1987) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544560 · Cited by 23
Recovery of the nasal mucosa following laureth-9 induced damage
Zhou, M., & Donovan, M. D. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04358-6 · Cited by 19 · cited 1×
“Slow mucosal recovery rates were observed with laureth-9 (Richardson et al 1991; Zhou and Donovan 1996).”
BackgroundAlternative Approaches to Oral Controlled Drug Delivery: Bioadhesives and In-Situ Systems
Park, K., Ch'Ng, H. S., & Robinson, J. R. (1984) · Springer eBooks · doi:10.1007/978-1-4613-2745-5_11 · Cited by 19 · cited 1×
“Polyanionic polymers are preferred over polycationic polymers with regard to bioadhesiveness (Park et al 1984; Peppas 1985; Leung & Robinson 1988; Duche# ne & Ponchel 1993).”
BackgroundThe potential use of tomato lectin for oral drug delivery: 4. Immunological consequences
Naisbett, B. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00398-o · Cited by 18 · cited 1×
“Although these lectins have yet to be investigated for use in nasal mucoadhesive drug delivery, they have proved very useful as drug targeting agents, enhancing drug delivery to the GIT (Irache 1994; Naisbett & Woodley 1995a, b; Ezpeleta et al 1999), and ocular cavity (Nicholls 1996).”
BackgroundAn aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidases
Hussain, M. A., Koval, C. A., Shenvi, A. B., & Aungst, B. J. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90324-k · Cited by 18
Buccal and nasal administration as an alternative to parenteral administration
Peppas, N. A. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90194-a · Cited by 17 · cited 1×
“Nasallyadministered psychotropic drugs by native Americans, the use of tobacco snuffs, and nasal administration of illicit drugs such as cocaine are all well known (Illum & Davis 1992).”
BackgroundNasal mucociliary function during the menstrual cycle in healthy women.
Armengot, M., Basterra, J., & Marco, J. (1990) · PubMed · Cited by 16
A Phosphinic Acid Dipeptide Analogue to Stabilize Peptide Drugs During Their Intranasal Absorption
Hussain, M. A., Lim, M. S. L., Raghavan, K. S., Rogers, N. J., Hidalgo, R., & Kettner, C. A. (1992) · Pharmaceutical Research · doi:10.1023/a:1015845925668 · Cited by 15
Nasal absorption of ergotamine tartrate in rats
HUSSAIN, A. A., Kimura, R., Chong-Heng, H., & Mustafa, R. (1984) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(84)90187-x · Cited by 14 · cited 1×
“…such as salicylic acid, aminopyrine, sulbenicillin, insulin, cefazolin, cephacetrile and phenol red (Hirai et al 1981), ergotamine tartrate (Hussain et al 1984), leucine enkephalin (Hussain et al 1985), sodium benzoate, sodium barbital, sodium phenobarbital, sodium pentobarbital, sodium…”
BackgroundEffect of Delivery Devices on Nasal Deposition and Mucociliary Clearance in Rhesus Monkeys
Hughes, B. L., Allen, D. L., Dorato, M. A., & Wolff, R. K. (1993) · Aerosol Science and Technology · doi:10.1080/02786829308959601 · Cited by 14 · cited 1×
“Hughes et al (1993) compared deposition and clearance of 99mTc-labelled sulfur colloids after intranasal administration to monkeys from compressed air nebulizer, nasal pump spray, drops from an instillation catheter and dry powder insufflator.”
BackgroundDEVELOPMENT OF A NEW NON-SURGICAL PERFUSION TECHNIQUE TO EVALUATE NASAL DRUG DELIVERY
Dondeti, P. (1991) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/thesis-dondeti-polireddy-1991 · Cited by 12 · cited 1×
“First described by Hirai et al (1981), various modifications of this in-situ perfusion technique have been made, including a non-surgical technique by Dondeti et al (1994).”
MethodMarom, Z. M., Shelhamer, J. H., & Kaliner, M. (1984) · PubMed · Cited by 11
Selection of volume indicator for the study of nasal drug absorption.
KOTANI, A., Hayashi, M., & Awazu, S. (1983) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.31.1097 · Cited by 10 · cited 1×
“HCl (Huang et al 1985a, b), hydralazine (Kaneo 1983), insulin and polyethylene glycol (Kotani et al 1983), and hydromorphine (Chang et al 1988).”
BackgroundThe Microbiology of Paranasal Sinus Infections: Diagnosis and Management
Rice, D. H. (1978) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408367809150917 · Cited by 10 · cited 1×
“A small increase in mucin causes a very large increase in mucus viscosity with a resultant prolongation of the mucociliary clearance time (Rice 1978).”
BackgroundRecovery of the rat vaginal epithelium from the histological effects of absorption enhancers
Richardson, J. L., Thomas, N. W., & Ilium, L. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90304-7 · Cited by 9 · cited 1×
“Slow mucosal recovery rates were observed with laureth-9 (Richardson et al 1991; Zhou and Donovan 1996).”
BackgroundAbsorption from the nasal mucous membrane. I. Nasal absorption of hydralazine in rats.
Kaneo, Y. (1983) · PubMed · Cited by 8
Nasal Delivery of Peptide Drugs
Arnold, J. J., Pillion, D. J., & Meezan, E. (2006) · CRC Press eBooks · doi:10.1201/9781420004816.ch20 · Cited by 6
Hm, D. (1986) · PubMed · Cited by 4
A review of the autonomic control of nasal function.
Babin, R. W. (1977) · PubMed · Cited by 2
Gayot, A. (1985) · PubMed · Cited by 2
Research works printed but not linked: 19
- Arnaud, 1993, Enhancers of gastrointestinal tract, 15
- Baroody, 1999, Anatomy and physiology, 1
- Burkitt, 1993, Wheater's Functional Histology
- Chien, 1995, Biopharmaceutics basis for transmucosal delivery. S.T.P, Pharma. Sci., 5, 257
- Illum, 1992, Nasal delivery of peptides, factors affecting nasal absorption, 71
- Illum, 1992, Microspheres for nasal administration, 125
- Kamath, 1994, Mucosal adhesive preparations, 133
- Lindberg, 1997, Mucociliary transport, 155
- Longer, 1986, Fundamental aspects of bioadhesion, Pharm. Int., 5, 114
- Petri, 1985, Development of metered-dose nebulizer for intranasal peptide administration, 161
- Proctor, 1977, The upper airways I. Nasal physiology and defence of the lungs, Am. Rev. Respir. Dis., 115, 97
- Rice, 1978, The microbiology of parasinus infections: diagnosis and treatment, CRC Crit. Rev. Clin. Lab. Sci., 9, 105
- Ridley, 1992, Drug delivery to the buccal and nasal cavities, anatomical and physiological considerations, 29
- Sanders, 1997, The deposition of solution-based and suspension-based aerosols from metered dose inhalers in healthy subjects and asthmatic patients, S. T. P. Pharma Sci., 7, 300
- Satir, 1985, Switching mechanisms in control of ciliary motility, Mod. Cell Biol., 4, 1
- Sciarra, 1986, Pharmaceutical aerosols, 589
- Sciarra, 1990, Aerosols, 1694
- Tobyn, 1996, Factors affecting in vitro gastric mucoadhesion II. Properties of polymer, Eur. J. Pharm. Biopharm., 42, 56
- Ugwoke, 1999, Development and Evaluation of Controlled Release Nasal Drug Delivery Systems of Apomorphine
Cited by
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
“The use of a suitable mucoadhesive system (like viscous formulation, mucoadhesive polymers, hydrogel, in situ gelations) improves the retention time and reduces the mucociliary clearance [88].”
BackgroundNasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
UGWOKE, M., AGU, R., VERBEKE, N., & KINGET, R. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.009 · Cited by 543
Self-citationVasvani, S., Kulkarni, P., & Rawtani, D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.066 · Cited by 473
Intranasal nanoemulsion based brain targeting drug delivery system of risperidone
Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435
“The formulation should be designed so as to provide a rapid transport of drug across nasal mucosa and a longer residence time in nasal cavity to overcome the nasal mucociliary clearance (Ugwoke et al., 2001).”
Metadata
- Authors
- Ugwoke, M. I., Verbeke, N., & Kinget, R.
- Affiliations
- KU Leuven (BE)
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-01
- Volume
- 53
- Issue
- 1
- Pages
- 3-21
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W1969948087
- Cited by
- 355
- References
- 131
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 17 · 2023: 19 · 2022: 18 · 2021: 9 · 2020: 18 · 2019: 11 · 2018: 19 · 2017: 9 · 2016: 14 · 2015: 13 · 2014: 13 · 2013: 15 · 2012: 17
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Pharmacy and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- intranasal drug delivery, mucoadhesion, nasal absorption, ciliary beating, mucociliary clearance, systemic drug administration, antiallergic drugs, nasal decongestants, protein and peptide delivery, intranasal immunization
- MeSH terms
- Administration, Intranasal, Animals, Binding Sites, Dogs, Humans, Mucous Membrane, Nasal Cavity, Permeability, Rabbits, Drug Delivery Systems, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.